The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Dillione Janet since 2012.
The trader's CIK number is 1489798.
At the time of the last reporting, Dillione Janet was the Executive VP and GM Healthcare of Cormedix Inc.. (stock ticker symbol CRMD).
Also see all insider trading activities at Cormedix Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2013 | NUAN | 0 | $0 | 63,430 | $1,215,001 | 0 | $0 |
2012 | NUAN | 0 | $0 | 40,000 | $1,015,200 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2019 | CRMD | 59,291 | $195,425 | 0 | $0 | 0 | $0 |
2018 | CRMD | 0 | $0 | 0 | $0 | 15,357 | $0 |
2017 | CRMD | 73,314 | $35,083 | 0 | $0 | 0 | $0 |
2015 | CRMD | 18,738 | $49,880 | 0 | $0 | 0 | $0 |
1. Nuance Communications, Inc. (NUAN)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2013-08-09 | NUAN | Sale | 63,430 | 19.16 | 1,215,001 |
2012-12-14 | NUAN | Sale | 15,000 | 22.00 | 330,075 |
2012-02-14 | NUAN | Sale | 25,000 | 27.41 | 685,125 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-08-16 | CRMD | Buy | 6,147 | 8.19 | 50,343 |
2019-05-15 | CRMD | Buy | 11,144 | 6.74 | 75,110 |
2019-03-18 | CRMD | Buy | 42,000 | 1.67 | 69,972 |
2018-02-21 | CRMD | Option Ex | 15,357 | .00 | 0 |
2017-12-12 | CRMD | Buy | 52,083 | .48 | 24,999 |
2017-05-15 | CRMD | Buy | 21,231 | .47 | 10,084 |
2015-09-22 | CRMD | Buy | 15,000 | 2.66 | 39,900 |
2016-06-08 | CRMD | Buy | 3,738 | 2.67 | 9,980 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dillione Janet (Executive VP and GM Healthcare of Cormedix Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.